ETTX NASDAQ
Entasis Therapeutics Holdings Inc.
1W: -0.5%
1M: +0.5%
3M: +18.4%
1Y: -11.3%
3Y: -65.5%
$2.19
Last traded 2022-07-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$47M
+13.1% ▲
Net Income
-$47M
+6.6% ▲
EPS (Diluted)
$-1.00
+52.4% ▲
EBITDA
-$47M
+6.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $5M | $7M | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +40.0% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $5M | $7M | $0 | $0 |
| Gross Margin | — | 100.0% | 100.0% | — | — |
| R&D Expenses | $26M | $33M | $40M | $41M | $37M |
| SG&A Expenses | $6M | $10M | $14M | $13M | $15M |
| Operating Expenses | $31M | $38M | $52M | $51M | $52M |
| Operating Income | -$31M | -$38M | -$47M | -$54M | -$47M |
| Operating Margin | — | -764.1% | -670.5% | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$30M | -$32M | -$43M | -$50M | -$47M |
| Tax Expense | $0 | $472K | $677K | $0 | $0 |
| Net Income | -$30M | -$33M | -$44M | -$50M | -$47M |
| Net Margin | — | -659.0% | -626.4% | — | — |
| EPS (Diluted) | $-8.05 | $-9.64 | $-3.33 | $-2.10 | $-1.00 |
| EBITDA | -$30M | -$32M | -$43M | -$50M | -$47M |
| Shares Outstanding | 4M | 3M | 13M | 24M | 47M |